Tag: IPO

Thai ethanol producer to use IPO funds for biogas power project

In Thailand, the country’s third-largest ethanol producer will use about 296 million shares from its upcoming IPO to fund a 3MW biogas power plant, along with reducing debt and increasing working capital. The power plant will supply the ethanol plant and is expected to significantly reduce its power costs. The two phases of the project […]

April 9, 2014 More

Myriant withdraws $125 million IPO without saying why

In Massachusetts, Myriant Corp has withdrawn its plans for a $125 million IPO without stating its reasons for doing so. The company had hired UBS Investment Bank, J.P. Morgan, Citi and Piper Jaffray as joint bookrunners for the deal.

January 10, 2014 More

Coskata shelves IPO for second time

In Illinois, Coskata has shelved its IPO plans for the second time, again citing unfavorable market conditions. The IPO was meant to raise $100 million to fund a natural gas to ethanol facility, backtracking from earlier plans to produce ethanol from biomass. Mascoma, Enerkem and Fulcrum Bioenergy have all pulled out of planned IPOs in […]

July 16, 2013 More

LanzaTech on the road for up to $80 million in new investment

In New Zealand, LanzaTech is on the hunt for new investors to put in between $60 million and $80 million this year while holding off on an IPO until a first plant is up and running, probably around 2015. The two plants under construction are for 10 million and 25 gallons each, both based in […]

May 15, 2013 More

BioAmber completes IPO

Raises $80M at $10 per share; becomes first new industrial biotech company to complete IPO in more than a year. What went right and how? Is the IPO window re-opening? In Minnesota, BioAmber announced the pricing of its initial public offering of 8 million units consisting of one share of common stock and one warrant […]

May 10, 2013 More

Attention biotech shoppers: Save 31% on BioAmber’s IPO

Will BioAmber complete its IPO? As the industry waits, fingers crossed, the biosuccinic developer sweetens the pot with warrants, lower share prices. In Canada, BioAmber has reduced the proposed price range for its IPO to $10-$12 per share, down from a $15-$17 range — as it seeks to keep the initial public offering on track. […]

May 8, 2013 More

BioAmber sets price range for $128M IPO

8 million share offering at $15-$17 aims to raise $128 million. “We are selling 8,000,000 shares of common stock,” begins BioAmber’s latest SEC update, written in IPO-legalese. “The initial public offering price of our common stock is expected to be between $15.00 and $17.00 per share, which is the equivalent of €11.48 and €13.01 per […]

April 12, 2013 More

Mascoma withdraws its biofuels IPO

In New Hampshire, Mascoma Corporation applied to the SEC for the withdrawal of its S-1 Registration Statement, thereby abandoning its contemplated IPO. “The Company has determined at this time not to proceed with the offering due to market conditions,” the SEC notice said, and noted that “The Company may undertake a subsequent private offering. In […]

March 26, 2013 More

46% expect to see biofuels IPOs in the next 12 months

Biofuels Industry Survey Results: Key findings ahead of the World Biofuels Markets Congress & Exhibition In a recent survey conducted with bioenergy leading industry experts ahead of the 8th annual World Biofuels Markets Congress & Exhibition, 51% of those who responded rated their government’s policy as supportive, while 15% rated them as very supportive. Alongside […]

December 10, 2012 More

Wall Street Journal article comments on negative market for cleantech

In the Wall Street Journal, an article focused on the alternative energy market noted the downturn of Amyris’s stock after its IPO in 2010, decliing over 80% in two years. The article discussed the higher profit margins accessible by oil refiners after the introduction of new drilling techniques in conjunction with the increasingly tough market […]

December 10, 2012 More